Thrombophilia Screening: Universal, Selected, or Neither?
- 4 January 2017
- journal article
- review article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 23 (8) , 893-899
Abstract
The utility of thrombophilia testing in clinical practice is still a matter of debate because studies have not shown a benefit in the reduction of recurrent venous thromboembolism (VTE) risk in patients with thrombosis, despite the clearly higher VTE risk for first thrombosis. Screening for thrombophilia is indicated in selected patients. Particularly in selected young patients, especially women of childbearing age, the knowledge of the genetic thrombophilic defect may help in specific situations to decrease the risk of VTE events. Avoidance of modifiable risk factors and/or prophylactic thromboembolic procedures may be evaluated in selected patients. A comprehensive workup including personal and familial history, clinical examination, and laboratory test results including hereditary thrombophilia remains helpful in assessing the cumulative risk and the management of this group of selected patients.Keywords
This publication has 66 references indexed in Scilit:
- Practice Bulletin No. 138Obstetrics & Gynecology, 2013
- Non-O Blood Type Is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the LiteratureSeminars in Thrombosis and Hemostasis, 2012
- The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort StudiesPLOS Medicine, 2010
- Thrombotic risk factors: Basic pathophysiologyCritical Care Medicine, 2010
- Genetics of venous thrombosisJournal of Thrombosis and Haemostasis, 2009
- Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relativesBlood, 2009
- Pregnancy Failure and Heritable ThrombophiliaSeminars in Hematology, 2007
- The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolismThrombosis and Haemostasis, 2005
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Recurrent Venous Thromboembolism in Patients with a Partial Deficiency of Protein SNew England Journal of Medicine, 1984